FDA panel recommends Moderna’s mRNA flu shot for older adults
NBC News
—
A Food and Drug Administration advisory panel on Thursday recommended the approval of Moderna’s mRNA-based flu shot for older adults.
FDA Panel Backs Moderna mRNA Flu Shot
- FDA panel recommends mRNA flu vaccine for older adults The Hill —
- FDA advisors unanimously vote to approve Moderna's mRNA after agency drama Ars Technica —
- Key FDA committee unanimously recommends its first vaccine since 2023 NPR —
- FDA panel backs first-of-its-kind flu vaccine using mRNA technology PBS —